Latest filing published 06 Oct 2021 for Strongbridge Biopharma plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Fredric J. Cohen in Strongbridge Biopharma plc, where the filings describe the role as senior executive. In total, 2 filings cover trades dated from 1 October 2021 to 5 October 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 October 2021, the filings show a transaction in Strongbridge Biopharma plc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations